Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Biomerica Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +5 vs. Q2 2025
- Shares held
- 88.8K
- +19.3K (+27.8%) vs. Q2 2025
- Total value
- $251.3K
- +$31.7K (+14.4%) vs. Q2 2025
- New holders
- 6
- 1 more added
- Sold out
- 1
- 3 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 45 | $128 | 0.00% | −2−4.3% | Reduced |
| UBS Group AG | 115 | $325 | 0.00% | −434−79.1% | Reduced |
| Harbour Investments, Inc. | 125 | $354 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 169 | $478 | 0.00% | +169 | New |
| Farther Finance Advisors, LLC | 169 | $478 | 0.00% | +169 | New |
| Tower Research Capital LLC (TRC) | 194 | $549 | 0.00% | +194 | New |
| CIBC Private Wealth Group, LLC | 512 | $1.45K | 0.00% | +100+24.3% | Added |
| Citigroup Inc | 800 | $2.26K | 0.00% | +800 | New |
| Hollencrest Capital Management | 1,450 | $4.10K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 3,603 | $10.2K | 0.00% | 00.0% | Unchanged |
| DRW Securities, LLC | 10,392 | $29.4K | 0.00% | +10,392 | New |
| Two Sigma Securities, LLC | 10,472 | $29.6K | 0.00% | +10,472 | New |
| BlackRock, Inc. | 18,636 | $52.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 20,983 | $59.4K | 0.00% | −680−3.1% | Reduced |
| Vanguard Group Inc | 21,127 | $59.8K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,880−100.0% | Sold out |